IL195412A0 - Methods and compositions using immunomodulatory compounds in combination therapy - Google Patents

Methods and compositions using immunomodulatory compounds in combination therapy

Info

Publication number
IL195412A0
IL195412A0 IL195412A IL19541208A IL195412A0 IL 195412 A0 IL195412 A0 IL 195412A0 IL 195412 A IL195412 A IL 195412A IL 19541208 A IL19541208 A IL 19541208A IL 195412 A0 IL195412 A0 IL 195412A0
Authority
IL
Israel
Prior art keywords
compositions
methods
combination therapy
immunomodulatory compounds
immunomodulatory
Prior art date
Application number
IL195412A
Other languages
English (en)
Original Assignee
Celgene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corp filed Critical Celgene Corp
Publication of IL195412A0 publication Critical patent/IL195412A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL195412A 2006-05-26 2008-11-20 Methods and compositions using immunomodulatory compounds in combination therapy IL195412A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80860206P 2006-05-26 2006-05-26
PCT/US2007/012495 WO2007139939A2 (en) 2006-05-26 2007-05-24 Methods and compositions using immunomodulatory compounds in combination therapy

Publications (1)

Publication Number Publication Date
IL195412A0 true IL195412A0 (en) 2009-08-03

Family

ID=38606531

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195412A IL195412A0 (en) 2006-05-26 2008-11-20 Methods and compositions using immunomodulatory compounds in combination therapy

Country Status (11)

Country Link
EP (1) EP2023912A2 (es)
JP (1) JP2009538318A (es)
KR (1) KR20090014393A (es)
CN (1) CN101495111A (es)
AU (1) AU2007267928A1 (es)
CA (1) CA2652888A1 (es)
IL (1) IL195412A0 (es)
MX (1) MX2008014912A (es)
RU (1) RU2426542C2 (es)
WO (1) WO2007139939A2 (es)
ZA (1) ZA200809956B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2249835A1 (en) * 2008-01-29 2010-11-17 Celgene Corporation Methods using immunomodulatory compounds for modulating level of cd59
US20150087687A1 (en) * 2012-03-23 2015-03-26 Dennis Brown Compositions and methods to improve the therapeutic benefit of indirubin and analogs thereof, including meisoindigo
EA037638B1 (ru) * 2013-08-22 2021-04-23 Ванда Фармасьютикалз Инк. Лечение множественной миеломы
US20160199323A1 (en) 2013-08-22 2016-07-14 Vanda Pharmaceuticals, Inc. Cancer treatment
JP2017511132A (ja) * 2014-03-26 2017-04-20 ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッドＴｈｅ Ｂｒｉｇｈａｍ ａｎｄ Ｗｏｍｅｎ’ｓ Ｈｏｓｐｉｔａｌ， Ｉｎｃ． ヒト造血幹／前駆細胞のエクスビボ拡大のための組成物および方法
WO2015175916A1 (en) * 2014-05-16 2015-11-19 Celgene Corporation Methods and compositions using 4-amino-2-(2,6 dioxo-piperidine-3-yl)-isoindoline-1,3-dione for treatment of cancers
WO2023034504A1 (en) * 2021-09-01 2023-03-09 Flagship Pioneering Innovations Vi, Llc Methods and compositions for inducing fetal hemoglobin, modulating erythroid cell lineages, and perturbing megakaryocyte lineages

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5629327A (en) * 1993-03-01 1997-05-13 Childrens Hospital Medical Center Corp. Methods and compositions for inhibition of angiogenesis
US7498171B2 (en) * 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
NZ572388A (en) * 2002-05-17 2010-05-28 Celgene Corp Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
KR20050057672A (ko) * 2002-10-24 2005-06-16 셀진 코포레이션 통증의 치료, 변형 및 관리를 위한 면역조절 화합물을포함하는 조성물 및 이의 사용 방법
US7563810B2 (en) * 2002-11-06 2009-07-21 Celgene Corporation Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
US20050043233A1 (en) * 2003-04-29 2005-02-24 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis
US20050143420A1 (en) * 2003-12-02 2005-06-30 Moutouh-De Parseval Laure Methods and compositions for the treatment and management of hemoglobinopathy and anemia
US20060058311A1 (en) * 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation

Also Published As

Publication number Publication date
RU2426542C2 (ru) 2011-08-20
JP2009538318A (ja) 2009-11-05
MX2008014912A (es) 2008-12-10
EP2023912A2 (en) 2009-02-18
ZA200809956B (en) 2010-07-28
CN101495111A (zh) 2009-07-29
KR20090014393A (ko) 2009-02-10
AU2007267928A1 (en) 2007-12-06
RU2008151713A (ru) 2010-07-10
WO2007139939A2 (en) 2007-12-06
CA2652888A1 (en) 2007-12-06
WO2007139939A3 (en) 2008-07-03

Similar Documents

Publication Publication Date Title
IL191072A0 (en) Therapeutic compositions and methods
EP2180873A4 (en) THERAPEUTIC DENTAL COMPOSITION AND RELATED METHODS
EP2182922A4 (en) ANTIGEN-ADJUVANS COMPOSITIONS AND METHOD
EP2035014A4 (en) FUCOIDANE PREPARATIONS AND METHODS
ZA201203709B (en) Immunogenic compositions and methods
EP1895838A4 (en) COMPOSITIONS AND METHODS
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
PL2705826T3 (pl) Kompozycja fluorku i sposoby mineralizacji zębów
EP1984015A4 (en) METHOD AND COMPOSITIONS FOR TREATING ASTHMA IN HUMANS AND OTHER PRIMATES
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
IL198723A0 (en) Methods and compositions for therapeutic treatment
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
IL194826A0 (en) Compositions and methods for cellular imaging and therapy
EP2083755A4 (en) MEDICAL KIT AND METHOD THEREFOR
EP1773386A4 (en) VACCINE COMPOSITIONS AND CORRESPONDING METHODS
GB0721291D0 (en) Methods and compositions
EP2088865A4 (en) METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS
GB0617171D0 (en) Novel compositions and methods
IL195412A0 (en) Methods and compositions using immunomodulatory compounds in combination therapy
IL196411A0 (en) Anti-cocaine compositions and treatment
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
GB0719526D0 (en) Compositions and methods
EP2032151A4 (en) COMBINATION THERAPY PROCESS AND FORMULATION
EP2097085A4 (en) THERAPEUTIC MATERIALS AND METHOD
GB0501348D0 (en) Compositions and methods